Researchers Submit Patent Application, 'Enhancement Of Tumor Response To Chemotherapy By Activation Of The Asmase/Ceramide Pathway Through Timed Administration Of A Short-Acting Anti-Angiogenic Agent', for Approval (USPTO 20230069622)

2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Angiogenesis Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors FUKS, Zvi [...]